THE COMPLEX OF MYXOMAS, SPOTTY PIGMENTATION, AND ENDOCRINE OVERACTIVITY
THE COMPLEX OF MYXOMAS, SPOTTY PIGMENTATION, AND ENDOCRINE OVERACTIVITY
复制标题
DOI:
10.1097/00005792-198507000-00007
复制
发表时间:
1985-01-01
期刊:
影响因子:
1.6
通讯作者:
GO, VLW
中科院分区:
文献类型:
--
作者:
CARNEY, JA;GORDON, H;GO, VLW
In 1984, we reported four Mayo Clinic patients with Cushing syndrome and an unusual bilateral adrenal disorder to which we gave the descriptive title “primary pigmented nodular adrenocortical disease”(31). A search of the literature had revealed 24 similar cases; in 3 of these, the disorder was familial. In one family, initially reported in 1980 by Schweizer-Cagianut et al., two siblings were af-fected: one sibling, who also had an eyelid “fibroma,” became hemiparetic 4 years after adrenalectomy; the other was thought to have neurofibro-matosis because of skin “fibromas.” A third sibling did not have the adrenal disorder but died at age 5 years of a cardiac myxoma (29). We were struck by the occurrence of two very rare conditions–primary pigmented nodular adrenocortical disease and cardiac myxoma–in the same family. Moreover, the patient who had the cardiac myxoma was very young, whereas the mean age at presentation with cardiac myxoma in the Mayo Clinic experience is 51 years (4). Might there be a pathogenic connection between the two disorders? None of the 4 Mayo Clinic patients with the peculiar adrenal condition, however, had symptoms or signs of cardiac myxoma, nor was cardiac myxoma reported in the 24 patients with primary pigmented nodular adrenocortical disease who were identified from the literature. To be satisfied that these two conditions were not related, we reviewed records of Mayo Clinic patients in whom cardiac myxoma had been con-firmed pathologically either after surgical removal or at autopsy. The Cushing syndrome had not oc-curred in the 51 Mayo Clinic patients who had been operated on for the tumor. But among the 29 pa-tients in whom a cardiac myxoma was found at autopsy, one had the characteristic adrenal pathol-